2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Pratibha Binder, MD, discusses key trials improving the array of treatment options for patients with endometrial cancer.
Pratibha Binder, MD, gynecologic oncologist, assistant professor of Obstetrics, Gynecology, and Reproductive Sciences, Moores Cancer Center, UC San Diego Health, discusses key trials improving the array of treatment options for patients with endometrial cancer.
Treatment options for patients with endometrial cancer were previously limited to chemotherapy, radiation, and endocrine therapy, Binder states. In the past 5 years several trials have shifted this treatment paradigm to incorporate more effective alternatives, such as single-agent checkpoint inhibitors and combination treatments, Binder continues.
Notably, these trials also showed that such treatments did not have to be reserved for later lines. Instead, patients are now able to receive effective treatment immediately after first recurrence or failure of first-line chemotherapy, Binder concludes.